Maxim Group Downgrades FibroBiologics to Hold

Benzinga Newsdesk www.benzinga.com Negative 84.5%

Neg 84.5% Neu 0% Pos 0%

Maxim Group analyst Michael Okunewitch downgrades FibroBiologics (NASDAQ:FBLG) from Buy to Hold.

Comments

No comments yet. Be the first!